Predicting the Cost and Pace of Pharmacogenomic Advances: An Evidence-Based Study

Genomic research had been widely expected to transform medicine, but progress has been slower than some have expected. To critics delays represent broken promises and/or a sign that at least some of the money spent on genomic research might have been better spent elsewhere.